About VACCINE CONGRESS 2025

Early Bird Discount available (50%) until this month

The 5^th International Conference on Vaccine Research is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meetings of their kind across the globe. The Vaccine Congress will be back on April 10-11, 2025, in Dubai, UAE, bringing together the most senior and informed industry experts across the entire vaccine landscape. With the theme "Innovations in Vaccine Science Bridging Research and Global Health," the congress will host over 3,000 attendees, 280 speakers, 150+ exhibitors, and plenty of start-ups over the course of 2 days.

With a multitude of tracks, it will cover everything vaccine-related from start to finish. From basic research to commercial manufacture, this one congress covers the whole vaccine value chain, where science, government, and manufacturers all come together to create ground-breaking progress. If you are involved in vaccines or are new to the field due to the pandemic, this is the most important meeting you will be part of in 2025.

Key Features:

• World-leading presentations: Given by industry-leading experts.
• Panel debates: Industry experts will debate the most prominent questions in the world of vaccines.
• Networking opportunities: Extended breaks and receptions offer the chance to meet fellow attendees from across the globe.
• Exhibition: Meet leading solution and service providers helping the vaccine community.
• Start-up zone: Offers a unique environment to meet VCs looking for early-stage opportunities and related companies.

Key Benefits of Attendance

• Cutting-Edge Advances: Learn about the latest in mRNA, COVID-19, and emerging disease vaccines.
• Global Vaccine Equity: Explore strategies to ensure worldwide vaccine access.
• Innovative Research: Discover breakthroughs in cancer, HIV, and immunotherapy vaccines.
• Knowledge: Gain insights into vaccine safety, epidemiology, and immunology.
• Manufacturing Innovations: Understand advancements in vaccine production and quality control.
• Address Challenges: Discuss solutions for antimicrobial resistance and vaccine hesitancy.
• Tech Integration: See how AI and big data are transforming vaccine research.
• Broad Coverage: Engage with diverse topics, including veterinary vaccines and One Health.
• Networking: Connect with leading experts and industry professionals.
• Future Trends: Stay updated on trends in paediatric vaccines, personalized vaccinology, and regulatory pathways.

Sessions & tracks

Track 01. mRNA Vaccine Innovations

This track will explore the transformative impact of mRNA technology on vaccine development. Discussions will cover recent breakthroughs, including advancements in mRNA platforms and their application in diseases like COVID-19. Attendees will gain insights into ongoing research, challenges in scaling production, and the future potential of mRNA vaccines. 

• mRNA technology
• vaccine platforms
• COVID-19, innovation

Track 02. Global Vaccine Equity

Addressing the disparities in vaccine access, this session will delve into strategies for achieving global vaccine equity. Topics will include innovative approaches to distribution, partnerships, and policies designed to overcome barriers and ensure that vaccines reach underserved populations. 

• vaccine access
• global health
• distribution

Track 03. COVID-19 Vaccine

This track will focus on the development and impact of COVID-19 vaccines. It will review the latest updates on vaccine efficacy, booster shots, and responses to emerging variants. The session will also address lessons learned and future implications for vaccine strategy. 

• COVID-19
• booster shots
• vaccine impact
• variants

Track 04. Cancer Vaccines and Immunotherapy 

This session will highlight advancements in cancer vaccines and immunotherapy. Discussions will cover new therapeutic approaches, recent clinical trial outcomes, and the potential for vaccines to enhance cancer treatment and prevention strategies. 

• cancer vaccines
• immunotherapy
• oncology
• treatment

Track 05. Vaccines Epidemiology & Immunology

Focusing on the epidemiological and immunological aspects of vaccines, this track will examine how vaccines influence disease patterns and immune responses in populations. The session will provide insights into vaccine efficacy and public health impacts. 

• Epidemiology
• Immunology
• disease patterns
• vaccine impact

Track 06. Antimicrobial Resistance (AMR)

This session will explore the role of vaccines in addressing antimicrobial resistance (AMR). Topics will include current research on vaccine strategies to combat resistant bacterial pathogens and efforts to mitigate the global threat of AMR. 

• antimicrobial resistance
• AMR
• bacterial pathogens
• vaccines

Track 07. Emerging Infectious Disease Vaccines

Covering vaccines for emerging and re-emerging infectious diseases, this track will discuss the latest research, development challenges, and strategies for responding to new disease threats. Attendees will learn about cutting-edge approaches to vaccine development for novel pathogens. 

• emerging diseases
• vaccine development
• infectious diseases
• research

Track 08. Veterinary Vaccine

This track will focus on advancements in veterinary vaccines, addressing new developments in animal health and their impact on zoonotic disease prevention. The session will highlight innovations in vaccine research for animals and their implications for public health. 

• veterinary vaccines
• animal health
• zoonotic diseases
• advancements

Track 09. Vaccine Research & Development

This session will provide a comprehensive overview of the vaccine research and development process. Topics will include the stages of development from initial research to clinical trials, challenges faced, and strategies for successful vaccine development. 

• vaccine development
• research stages
• clinical trials
• challenges

Track 10. Infectious and Non-Infectious Diseases

Exploring vaccines for both infectious and non-infectious diseases, this track will cover their development, effectiveness, and global health impact. Discussions will include strategies to address a broad spectrum of diseases through vaccination. 

• infectious diseases
• non-infectious diseases
• vaccine effectiveness
• global health

Track 11. Novel Adjuvants & Delivery Systems

This session will examine innovations in adjuvants and vaccine delivery systems designed to enhance vaccine efficacy and improve administration. Attendees will learn about new technologies and methodologies that are shaping the future of vaccine delivery. 

• Adjuvants
• delivery systems
• vaccine efficacy
• innovations

Track 12. Vaccine Safety & Immunogenicity

Focusing on vaccine safety and immunogenicity, this track will review recent findings on vaccine safety profiles and immune responses. Discussions will include best practices for ensuring vaccines are both safe and effective across diverse populations. 

• vaccine safety
• immunogenicity
• safety profiles
• best practices

Track 13. Clinical Trials

This session will cover the design, execution, and outcomes of clinical trials for vaccines. It will provide insights into methodologies, data analysis, and the critical role of clinical trials in advancing vaccine research and development. 

• clinical trials
• vaccine testing
• research methodologies
• outcomes

Track 14. Pediatric Vaccines: Trends & Future

Discussing the latest trends in pediatric vaccines, this track will explore innovations, challenges, and future directions in vaccines specifically for children. The session will highlight new research and strategies to improve vaccine delivery and coverage for pediatric populations. 

• paediatric vaccines
• trends, innovations
• challenges

Track 15. Vaccine Manufacturing Advances

This track will focus on recent advancements in vaccine manufacturing technologies, including improvements in production processes, scalability, and quality control. Attendees will gain insights into the latest trends and technologies driving efficiency in vaccine production. 

• vaccine manufacturing
• production technologies
• scalability
• quality control

Track 16. Regulatory Pathways in Vaccines

Covering the regulatory landscape for vaccine development, this session will review the approval processes, regulatory challenges, and strategies for navigating the complex environment to bring vaccines to market successfully. 

• Regulatory pathways
• Vaccine approval
• Regulatory challenges
• Compliance

Track 17. Vaccine-Preventable Diseases

This track will review both the successes and ongoing challenges in addressing vaccine-preventable diseases. Discussions will focus on strategies to maintain and improve vaccine coverage and effectiveness in combating diseases that vaccines can prevent. 

• vaccine-preventable diseases
• vaccine coverage, successes, challenges

Track 18. One Health: Zoonotic Disease Vaccines

Exploring the One Health approach, this session will discuss vaccines for zoonotic diseases and how interconnected human, animal, and environmental health efforts can enhance vaccine development and disease prevention. 

• One Health
• zoonotic diseases
• interconnected health, vaccines

Track 19. Influenza & Respiratory Virus Vaccines

This track will cover advancements in vaccines for influenza and other respiratory viruses. Topics will include new developments, effectiveness, and strategies for addressing seasonal and pandemic threats associated with respiratory viruses. 

• Influenza vaccines,
• respiratory viruses
• vaccine developments
• pandemic threats

Track 20. Vaccine Hesitancy & Public Engagement

Addressing vaccine hesitancy, this session will explore strategies for improving public engagement and communication. Discussions will focus on overcoming misinformation and increasing vaccine uptake through effective public health messaging. 

• vaccine hesitancy
• public engagement
• communication strategies
• misinformation

Track 21. Personalized Vaccinology

This track will delve into personalized vaccinology, exploring how vaccines can be tailored to individual genetic and environmental factors to enhance their efficacy. The session will discuss emerging approaches and future directions in personalized vaccine development. 

• personalized vaccinology
• genetic factors
• vaccine tailoring, efficacy

Track 22. HIV Vaccines

Focusing on the latest research and developments in HIV vaccines, this session will discuss ongoing challenges, recent breakthroughs, and future directions in the fight against HIV/AIDS. Attendees will gain insights into innovative approaches and research findings in HIV vaccine development. 

• HIV vaccines
• research developments
• challenges, advancements

Track 23. AI & Big Data in Vaccine Research

This track will explore how artificial intelligence and big data are transforming vaccine research. Discussions will include how these technologies are used to accelerate vaccine discovery, enhance research methodologies, and improve data analysis for better vaccine development outcomes. 

• AI, big data,
• vaccine research, technology

Market Analysis

Market Analysis of VACCINE CONGRESS 2025

The global vaccine research market is rapidly expanding, driven by increased demand for innovative vaccines and significant advancements in biotechnology. The COVID-19 pandemic has spurred a surge in investment and focus on vaccine development, emphasizing the importance of enhanced pandemic preparedness. Technological innovations such as mRNA and vector-based vaccines are leading the way, supported by rising public and private sector funding. Key industry players include major pharmaceutical and biotech companies, often collaborating to advance research. Despite challenges like regulatory hurdles and vaccine hesitancy, the market is expected to grow, influenced by trends in personalized medicine, digital health technologies, and global health initiatives.

Key Highlights:

• Technological Advancements: Significant progress in vaccine technology, including mRNA and vector-based vaccines.
• Investment Surge: Increased funding from both public and private sectors.
• Emerging Trends: Focus on personalized vaccines and digital health integration.
• Geographic Expansion: Growth in both developed and emerging markets.

Visa Trip Advisor

Planning a trip to Dubai, UAE? Attend our Meeting!

Issue with VISA?

To support participants in their VISA application process, we provide VISA support documents as follows:

1. Official Letter of Invitation
2. Official Letter of Abstract Acceptance
3. Receipt of Payment

Points to note:

• Visa Letter (official letter of invitation) will be issued only after successful registration and payment for the conference.
• Visa Letters can be issued only for the individual accepted to attend the conference.
• Please contact the Program Manager, Josephine, via vaccine@euroannualmeetings.com  to arrange for a Visa Letter.

Kindly provide us with the following information for Visa Letters:

• Your name as it appears on your passport
• Passport Scan Copy (for passport number and date of birth)
• Abstract Acceptance letter for Presenters

Payment Methods:

1. Payment Gateway/RAZORPAY
2. Bank-to-Bank transfer

Having trouble with registration?

Please contact Program Manager Josephine via vaccine@euroannualmeetings.com. The VACCINE CONGRESS 2025 team will provide you with an INVOICE for the requested price, enabling you to make the Bank-to-Bank transfer.

Past Conference Report

The 2024 International Conference on Vaccine Research, held in Madrid Spain, was a landmark event that drew over 2,500 attendees from around the world. Featuring 250 leading experts and 120 exhibitors, the conference provided a comprehensive overview of the latest advancements in vaccine science. Key sessions included cutting-edge discussions on mRNA vaccine technology, updates on COVID-19 vaccines, strategies for achieving global vaccine equity, and innovations in cancer vaccines.

Attendees enjoyed valuable networking opportunities during extended breaks and evening receptions, fostering collaboration and knowledge exchange. The Start-Up Zone showcased 30 emerging companies, offering insights into the future of vaccine development and investment opportunities. The conference also highlighted the transformative role of artificial intelligence and big data in accelerating vaccine research and improving public health outcomes.

Overall, the conference successfully set the stage for future advancements in the field. The next International Conference on Vaccine Research is scheduled for April 2025 in Dubai, where it will continue to explore emerging trends and global health initiatives.

Past Conference Report

VACCINE CONGRESS 2024

test